ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinomaNicole Concin, Carien L. Creutzberg|International Journal of Gynecological Cancer|2020Cited by 1.9k
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent diseaseNicoletta Colombo, Cristiana Sessa, Andreas du Bois et al.|Annals of Oncology|2019Cited by 1.2k
<scp>FIGO</scp> staging of endometrial cancer: 2023Jonathan S. Berek, Nicole Concin, Xavier Matías‐Guiu et al.|International Journal of Gynecology & Obstetrics|2023Cited by 926
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent diseaseJonathan A. Ledermann, Anna Fagotti, Xavier Matías‐Guiu et al.|Annals of Oncology|2024Cited by 277
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trialJohann S. de Bono, Ulrik Lassen, Nicole Concin et al.|The Lancet Oncology|2019Cited by 228